Emerald Advisers’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,635	Closed	-$271K	–	249
2023 Q2	$271K	Buy	+2,635	New	+$278K	0.01%	202
2022 Q4	–	Sell	-23,478	Closed	-$1.45M	–	269
2022 Q3	$1.45M	Sell	23,478 -8,526	-27%	-$596K	0.08%	129
2022 Q2	$2.55M	Buy	32,004 +1,482	+5%	+$140K	0.13%	116
2022 Q1	$3.21M	Buy	30,522 +1,083	+4%	+$106K	0.12%	122
2021 Q4	$3.17M	Sell	29,439 -2,406	-8%	-$262K	0.12%	126
2021 Q3	$3.49M	Sell	31,845 -839	-3%	-$87.1K	0.13%	120
2021 Q2	$3.06M	Hold	32,684	–	–	0.11%	126
2021 Q1	$3.01M	Sell	32,684 -17,440	-35%	-$1.47M	0.11%	124
2020 Q4	$3.67M	Sell	50,124 -589,441	-92%	-$43.8M	0.12%	125
2020 Q3	$49.7M	Sell	639,565 -225,325	-26%	-$15.5M	2.04%	5
2020 Q2	$48.1M	Sell	864,890 -360,306	-29%	-$15.4M	2.09%	3
2020 Q1	$36.3M	Buy	1,225,196 +18,262	+2%	+$618K	2.1%	5
2019 Q4	$43.7M	Sell	1,206,934 -625	-0.1%	-$19.2K	1.85%	6
2019 Q3	$32.9M	Sell	1,207,559 -103,519	-8%	-$2.68M	1.54%	16
2019 Q2	$31.5M	Sell	1,311,078 -18,116	-1%	-$460K	1.27%	25
2019 Q1	$35.1M	Buy	1,329,194 +389,718	+41%	+$9.23M	1.43%	15
2018 Q4	$18.4M	Buy	+939,476	New	+$18.4M	0.9%	43
2016 Q3	–	Sell	-204,797	Closed	-$3.37M	–	330
2016 Q2	$3.37M	Buy	204,797 +99,679	+95%	+$1.61M	0.16%	155
2016 Q1	$1.74M	Buy	+105,118	New	+$1.84M	0.08%	208
2015 Q2	–	Sell	-424,266	Closed	-$12.5M	–	389
2015 Q1	$12.5M	Sell	424,266 -511,389	-55%	-$9.37M	0.63%	49
2014 Q4	$12.1M	Buy	935,655 +238,522	+34%	+$2.99M	0.64%	48
2014 Q3	$8.56M	Sell	697,133 -210,458	-23%	-$2.45M	0.51%	65
2014 Q2	$14.4M	Buy	907,591 +90,181	+11%	+$1.29M	0.81%	28
2014 Q1	$12.4M	Buy	+817,410	New	+$9.23M	0.7%	36